- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/26 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Patent holdings for IPC class C07D 211/26
Total number of patents in this class: 380
10-year publication summary
23
|
28
|
35
|
20
|
19
|
12
|
24
|
14
|
22
|
10
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novartis AG | 10744 |
11 |
Concentric Analgesics, Inc. | 23 |
11 |
Janssen Pharmaceutica N.V. | 3394 |
10 |
Incyte Corporation | 1022 |
10 |
Incyte Holdings Corporation | 666 |
9 |
Glaxosmithkline Intellectual Property Development Limited | 762 |
7 |
Boehringer Ingelheim International GmbH | 4642 |
6 |
ChemoCentryx, Inc. | 386 |
6 |
Richter Gedeon Nyrt. | 1635 |
6 |
Praxis Precision Medicines, Inc. | 174 |
6 |
Oryzon Genomics S.A. | 106 |
5 |
Hoffmann-La Roche Inc. | 3439 |
4 |
Glaxosmithkline Intellectual Property (no.2) Limited | 287 |
4 |
Massachusetts Institute of Technology | 10062 |
4 |
Astellas Pharma Inc. | 1087 |
4 |
SK Biopharmaceuticals Co., Ltd. | 262 |
4 |
Libertas bio, Inc. | 17 |
4 |
F. Hoffmann-La Roche AG | 7947 |
3 |
Merck Patent GmbH | 5815 |
3 |
FUJIFILM Corporation | 29437 |
3 |
Other owners | 260 |